Bioengineering Department Chair Statement

A statement on the future of Bioengineering from Department Chair, Peter Lelkes.

Bioengineering Department Chair Statement

The Bioengineering Department has transitioned from the initial rapid growth phase—from 18 during our inaugural year to our current 280 undergraduate and 50 graduate students, in five years. This past academic year has seen the graduation of our first full class of 34 undergraduates, many of whom have gone on to graduate school, medical school and a variety of jobs in industry.

We now have entered the phase of consolidation, focusing on solidifying our programmatic offerings, especially on refining the teaching and research infrastructure. After only five years in existence, our graduate program has been ranked by U.S. News & World Report, the highest ranking among all the graduate programs in our College.

We also continue to expand our close collaborations with renowned laboratories at the Temple School of Medicine and the Fox Chase Cancer Center, where some of our graduate students work on collaborative interdisciplinary projects and are jointly mentored by Bioengineering, Temple School of Medicine and Fox Chase faculty.

The research of both our faculty and our students has been recognized by numerous publications and awarded several national grants. Also, this year we welcomed the largest cohort of new graduate students, including eight new PhD and six new MS students. 

Quite a few of our MS students are graduates of the BS part of our 4+1 program and continue with us to complete the graduate degrees. We have firmly established our summer undergraduate research program, as well as the weekly departmental seminar series with prominent guest lecturers, alternating between seminars focusing on cutting-edge research and professional development.

While we are excited about our achievements, we look forward to continuing to strengthen our program into the future. 

Peter I. Lelkes

Laura H. Carnell Professor and Chair